Given the evidence of Type 2 diabetes which was recently provided and Type 2 diabetes introduced as an inflammatory disease, it can be expected that high expression of this receptor (CCR5) on the level of single–cellular cells of the blood increases inflammatory responses and increases the risk of type 2 diabetes. This evidence concerns the gene CCR5 and type 2 diabetes mellitus.